Renerva, Inc.
Biotechnology company · Pittsburgh, Pennsylvania, United States
Renerva, Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, United States. Its earliest recorded incorporation is in 2017. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $324,820 sold in a notice filed in 2025.
Renerva at a glance
What does Renerva do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $1.8 million in total (2019 to 2025). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Institute on Deafness and Other Communication Disorders.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $324,820 sold (2025).
Frequently asked questions about Renerva
Where is Renerva headquartered?
Renerva, Inc. is headquartered in Pittsburgh, Pennsylvania, United States.
What does Renerva do?
Renerva, Inc. is a biotechnology company.
When was Renerva founded?
The earliest incorporation on record for Renerva, Inc. is in 2017, according to public company registers.
Similar companies
- Krystal Biotech, Inc.Pittsburgh, Pennsylvania, United States
- CytoAgents, Inc.Pittsburgh, Pennsylvania, United States
- Knopp Biosciences LLCPittsburgh, Pennsylvania, United States
- Noveome Biotherapeutics, Inc.Pittsburgh, Pennsylvania, United States
- Cohera Medical IncPittsburgh, Pennsylvania, United States
- Carmell Therapeutics CorpPittsburgh, Pennsylvania, United States
- Globin Solutions, Inc.Pittsburgh, Pennsylvania, United States
- Celsense IncPittsburgh, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences